A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma
暂无分享,去创建一个
I. Lossos | V. Seshan | A. Zelenetz | S. Schuster | J. Westin | A. Jacob | Anita Kumar | G. Nowakowski | G. Masand | Chelsea D. Mullins | E. Napier | A. Joseph | L. Laraque | S. Vemuri | Clare Grieve | Devin Copley | Tania Rodriguez